Another virtual event open to the whole community! At SOLACI we want to continue promoting continuous medical education and, in that sense, to expand the development of interventional cardiology in Latin America. For this reason, we bring you a new educational proposal, this time an Update on the treatment of acute coronary syndromes without ST…
Diabetes Could Decide between Ticagrelor and Prasugrel
Diabetes has an impact on the relative effect of ticagrelor and prasugrel in patients undergoing acute coronary syndrome (ACS) according to a recent analysis of the ISAR-REACT 5 published in JACC Intv. Similarly to the main study outcomes, this sub-analysis of the ISAR-REACT 5 has shown that the combined end point of death, MI or…
Computerized Tomography as First Coronary Study?
According to this new document recently published in JACC, a computerized tomography (CT) coronary angiography should be the first study done to diagnose a stable coronary artery disease. A multidisciplinary group of experts recommends using computerized tomography as first-line diagnosis in stable patients. According to these professionals, guidelines should be updated soon. Given the accruing…
Infarction, Stroke and Aortic Emergency Syndromes in the Shadow of the Pandemic
The coronavirus pandemic has had a negative impact on the most pressing cardio and neurological emergencies, such as strokes or aortic dissection. These emergencies are normally treated in high complexity centers, which is why it is relatively simple to analyze the number of transfers before and after the pandemic. For some time, care centers have…
Webinar SOLACI | NSTE-ACS Revascularization: Times and Methods in the COVID-19 Era
Watch again our Webinar on “NSTE-ACS Revascularization: Times and Methods in the COVID-19 Era” on our Youtube account. We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.
SOLACI Webinar | NSTE-ACS Revascularization: Times and Methods in the COVID-19 Era
[wysija_form id=”3″] We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.